Xylem (NYSE:XYL) Stock Gets Price Target Cut from Oppenheimer

Posted by Geri Gentry on Oct 31st, 2026

Xylem (NYSE:XYL – Free Report) had its price target cut by Oppenheimer from $150.00 to $135.00 in a report released on Wednesday,Benzinga reports. They currently have an outperform rating on the industrial products company’s stock.

XYL has been the subject of several other reports. Weiss Ratings reissued a “hold (c)” rating on shares of Xylem in a research report on Wednesday, August 5th. Citigroup dropped their target price on shares of Xylem from $172.00 to $148.00 and set a “buy” rating on the stock in a research note on Monday, October 12th. Royal Bank Of Canada decreased their price target on shares of Xylem from $135.00 to $125.00 and set an “outperform” rating for the company in a research note on Wednesday. Mizuho lowered their price target on Xylem from $130.00 to $110.00 and set a “neutral” rating for the company in a report on Thursday, October 15th. Finally, Barclays dropped their price objective on Xylem from $159.00 to $139.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 13th. Nine equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Xylem presently has an average rating of “Hold” and a consensus price target of $121.31.

View Our Latest Stock Analysis on XYL

Xylem Stock Performance

NYSE XYL opened at $92.41 on Wednesday. The business’s 50 day moving average price is $105.05 and its 200-day moving average price is $117.57. Xylem has a fifty-two week low of $87.40 and a fifty-two week high of $152.43. The company has a market cap of $21.19 billion, a P/E ratio of 20.44, a P/E/G ratio of 1.51 and a beta of 1.00. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.39.

Xylem (NYSE:XYL – Get Free Report) last posted its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 EPS for the quarter, missing the consensus estimate of $1.45 by ($0.01). Xylem had a return on equity of 12.06% and a net margin of 11.94%. The firm had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.28 billion. During the same period in the previous year, the firm earned $1.37 earnings per share. The firm’s quarterly revenue was down 3.0% compared to the same quarter last year. Sell-side analysts predict that Xylem will post 5.45 earnings per share for the current year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, September 24th. Investors of record on Thursday, August 27th were issued a $0.43 dividend. This represents a $1.72 annualized dividend and a yield of 1.9%. The ex-dividend date was Thursday, August 27th. Xylem’s dividend payout ratio (DPR) is 40.95%.

Insider Transactions at Xylem

In other news, Director D Koch bought 11,000 shares of the stock in a transaction that occurred on Thursday, October 29th. The stock was purchased at an average price of $89.60 per share, for a total transaction of $985,600.00. Following the completion of the purchase, the director owned 12,247 shares in the company, valued at approximately $1,097,331.20. This trade represents a 882.12% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.32% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Xylem

A number of institutional investors have recently made changes to their positions in XYL. XXEC Inc. acquired a new position in Xylem during the second quarter worth $850,841,000. BlackRock Inc. acquired a new stake in Xylem in the 2nd quarter worth approximately $2,959,730,000. State Street Corp lifted its holdings in Xylem by 2.4% in the 2nd quarter. State Street Corp now owns 11,444,669 shares of the industrial products company’s stock worth $1,352,874,000 after purchasing an additional 270,972 shares during the last quarter. Swedbank AB boosted its holdings in shares of Xylem by 0.3% during the 1st quarter. Swedbank AB now owns 5,526,725 shares of the industrial products company’s stock worth $660,444,000 after buying an additional 18,759 shares during the period. Finally, Royal Bank of Canada lifted its position in shares of Xylem by 1.1% during the 1st quarter. Royal Bank of Canada now owns 4,763,241 shares of the industrial products company’s stock worth $569,207,000 after purchasing an additional 53,210 shares during the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

More Xylem News

Here are the key news stories impacting Xylem this week:

Positive Sentiment: Director D. Christian Koch purchased 11,000 Xylem shares for approximately $985,600 at an average price of $89.60. The transaction increased his direct holdings more than eightfold and may signal confidence that the recent selloff has created an attractive entry point. Insider purchase report
Positive Sentiment: Some analysts continue to see longer-term value. RBC Capital reaffirmed its buy rating, while RBC’s new coverage assigned a moderate-buy rating and a $125 price target, implying substantial upside from recent levels. RBC rating report
Neutral Sentiment: Xylem announced divestitures and a new three-segment operating structure. The changes could sharpen strategic focus and improve portfolio efficiency, but execution and transition risks remain. Xylem restructuring report
Negative Sentiment: Xylem’s latest quarter missed expectations: EPS was $1.44 versus $1.45 expected, revenue was $2.20 billion versus $2.28 billion expected, and sales declined 3% year over year. Management’s new 2026 adjusted-EPS ceiling of $5.45 is below the prior $5.55 floor, reinforcing concerns about weaker growth.
Negative Sentiment: Barclays downgraded Xylem to equal weight from overweight, JPMorgan lowered its rating to underweight, and UBS, Stifel, BNP Paribas Exane, Citigroup and Oppenheimer reduced price targets. The revisions reflect diminished near-term earnings and valuation expectations. Barclays downgrade report
Negative Sentiment: Levi & Korsinsky announced an investigation into potential securities-law violations related to investor losses, adding legal uncertainty and another possible overhang for XYL shareholders. Investigation announcement

Xylem Company Profile

(Get Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.